AzTrials
AzTrials

SubluxationSHANCT06931600

Simulated vs Genuine Manual Chiropractic Adjustments

A study testing Chiropractic adjustment in people with Subluxation, run by Life University at 1 site in United States.

Suspended

Paused. Enrolment is on hold for now and may resume.

Official record
Search all trials

Trial summary

Our primary aim with this trial is to measure participant blinding following two simulated/sham or genuine/real high velocity, low amplitude (HVLA) manual chiropractic adjustments to assess if participants are able to identify their un-disclosed treatment group. Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Subluxation
What is being tested?
Chiropractic adjustment
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
60 participants
Where
1 siteUnited States
Study dates
5 May 2025to May 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult
  • No history of stroke or transient ischemic attack or current symptoms including: Dizziness or vertigo; Tinnitus (ringing in the ears); Visual, sensory, or motor disturbances
  • No new pattern headache complaint
  • No recent whiplash injury (within 3 mo)
  • No spinal fractures/dislocations
  • No disc problems with radiating symptoms to the arms or legs
  • No severe degenerative joint disease in the spine
  • No connective tissue disorders
  • No primary fibromyalgia
  • No metabolic or metaplastic bone disease
  • No diagnosed condition that causes fainting during postural changes, such as POTS or orthostatic hypotension
  • No history of cervical, thoracic, or lumbar spine surgery
  • No uncontrolled high blood pressure or vascular disease
  • No current use of anticoagulant therapy
  • No current use of short-acting benzodiazepines, including midazolam \& triazolam
  • No change in medications in the past 6 weeks or intentions to change medications during the study
  • Inability to walk unassisted on a treadmill
  • No pacemakers or known heart conditions that influence the electrical or mechanical function of the heart, such as severe heart valve disease
  • Not a DC or a DC student enrolled 4th quarter or above
  • No present, self-reported pregnancy
  • No chiropractic care in the 2 weeks prior to participation
  • Did not participate in the feasibility study for this pilot (Perceptions and experiences following a single session of simulated or genuine high velocity, low amplitude (HVLA) manual chiropractic adjustments)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Dr. Sid E. Williams Center for Chiropractic Research

    Marietta, Georgia, 30067

Other trials in United States

About this study

Official title: Blinding Integrity Following Multiple Sessions of Simulated or Genuine High Velocity, Low Amplitude (HVLA) Manual Chiropractic Adjustments: a Pilot Study

Our primary aim with this trial is to measure participant blinding following two simulated/sham or genuine/real high velocity, low amplitude (HVLA) manual chiropractic adjustments to assess if participants are able to identify their un-disclosed treatment group. Our secondary aims with this trial are to utilize electrocardiography (ECG), impedance cardiography (ICG), and gait analysis before either treatment session and after both treatment sessions to assess if there are any changes with the participants' measurements before and after a sham or genuine HVLA chiropractic treatment.

Read the detailed description

The primary aim of this trial is to assess blinding following simulated/sham or genuine/real high velocity, low amplitude (HVLA) manual chiropractic adjustments. Briefly, 60 eligible participants will be randomized (1:1 ratio) to receive two sessions of either simulated/sham or genuine/real chiropractic spinal adjustments with a 1 week washout between each treatment. The participants will be given a brief survey immediately following their first and second sessions, as well as immediately prior to the second session. This survey captures their perceptions and experiences regarding the intervention they received. The participants will also complete a pre- and post-electrocardiogram (ECG), impedance cardiography (ICG), and gait analysis. The participant will wear electrical diodes to assess ECG and ICG. Additional sensors will be placed on the participant to assess gait patterns while walking on a treadmill.

Conditions
Subluxation
Being tested
Sham adjustment, Chiropractic adjustment
Keywords
randomized, sham-controlled, chiropractic, blinding, gait analysis, impedance cardiography, movement parameters, electrocardiography, autonomic nervous system, Heart Rate Variability
Medical subject headings
Joint Dislocations

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sham adjustmentProcedure or surgery

    Two manual high velocity, low amplitude (HVLA) simulated/sham chiropractic interventions in the cervical, thoracic, and/or lumbopelvic regions

  • Chiropractic adjustmentProcedure or surgery

    Two manual high velocity, low amplitude (HVLA) genuine/real chiropractic interventions in the cervical, thoracic, and/or lumbopelvic regions

Study groups in NCT06931600
Study groupRoleWhat they receive
Simulated/shamSham comparator30 individuals receiving simulated/sham chiropractic interventions
Receives: Procedure: Sham adjustment
Genuine/realExperimental30 individuals receiving genuine/real chiropractic interventions
Receives: Procedure: Chiropractic adjustment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Participant blinding

    The blinding index is scaled to an internal of -1 to +1, +1 being complete lack of blinding, 0 being consistent with perfect blinding, -1 indicating opposite guessing which may be related to unblinding.

    Measured: Immediately post-session 1 (day 1)

  2. Participant blinding

    The blinding index is scaled to an internal of -1 to +1, +1 being complete lack of blinding, 0 being consistent with perfect blinding, -1 indicating opposite guessing which may be related to unblinding.

    Measured: Immediately pre-session 2 (day 2)

  3. Participant blinding

    The blinding index is scaled to an internal of -1 to +1, +1 being complete lack of blinding, 0 being consistent with perfect blinding, -1 indicating opposite guessing which may be related to unblinding.

    Measured: Immediately post-session 2 (day 2)

Secondary outcomes (12)
  1. High-frequency Heart Rate Variability (HF-HRV)

    3 sensors on torso. HF-HRV indexes fluctuations in the heart period that occur within the 0.12 to 0.5 Hz frequency range

    Measured: baseline

  2. High-frequency Heart Rate Variability (HF-HRV)

    3 sensors on torso. HF-HRV indexes fluctuations in the heart period that occur within the 0.12 to 0.5 Hz frequency range.

    Measured: post-session 2 (day 2)

  3. Pre-ejection period (PEP)

    3 ECG sensors on the torso + 4 ICG sensors (2 sensors on chest and 2 sensors on back). The PEP is the time interval between the electrical depolarization of the heart (Q-wave on ECG) and the beginning of blood ejection from the heart (B-point on ICG).

    Measured: baseline

  4. Pre-ejection period (PEP)

    3 ECG sensors on the torso + 4 ICG sensors (2 sensors on chest and 2 sensors on back). The PEP is the time interval between the electrical depolarization of the heart (Q-wave on ECG) and the beginning of blood ejection from the heart (B-point on ICG).

    Measured: post-session 2 (day 2)

  5. The speed of the participants will be assessed at baseline as part of the gait analysis.

    16 inertial measurement unit (IMU) sensors (noraxon) and treadmill output measurements

    Measured: baseline

  6. The speed of the participants will be assessed again at post-session 2 as part of the gait analysis.

    16 inertial measurement unit (IMU) sensors (noraxon) and treadmill output measurements

    Measured: post-session 2 (day 2)

  7. Force measurements generated during walking will be assessed at baseline as part of the gait analysis.

    16 inertial measurement unit (IMU) sensors (noraxon) and treadmill output measurements

    Measured: baseline

  8. Force measurements generated during walking will be assessed again at post-session 2 as part of the gait analysis.

    16 inertial measurement unit (IMU) sensors (noraxon) and treadmill output measurements

    Measured: post-session 2 (day 2)

  9. Gait symmetry will be assessed at baseline as part of the gait analysis.

    16 inertial measurement unit (IMU) sensors (noraxon)

    Measured: baseline

  10. Gait symmetry will be assessed again at post-session 2 as part of the gait analysis.

    16 inertial measurement unit (IMU) sensors (noraxon)

    Measured: post-session 2 (day 2)

  11. Root Mean Square of Successive Differences (RMSSD)

    3 sensors on torso. RMSSD is a measure of heart rate variability (HRV) that focuses on short-term beat-to-beat changes in the heart period.

    Measured: baseline

  12. Root Mean Square of Successive Differences (RMSSD)

    3 sensors on torso. RMSSD is a measure of heart rate variability (HRV) that focuses on short-term beat-to-beat changes in the heart period.

    Measured: post-session 2 (day 2)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Apr 2025
  2. Study start5 May 2025
  3. Primary completionApr 2026 (estimated)
  4. Study completionMay 2026 (estimated)

Why it stopped: Funding

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
randomized, sham-controlled, pilot study
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06931600
Sponsor's protocol ID
I-0032
Acronym
SHA
Status last verified
Mar 2026
First submitted
28 Mar 2025
Last updated
30 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Sliwka M, Perez T, Qazi A, Sullivan S. Spinal Manipulative Therapy on a Healthy Population: Protocol for a Randomized Blinding Feasibility Trial. JMIR Res Protoc. 2026 Mar 27;15:e85956. doi: 10.2196/85956.

    PubMed 41894654

Questions about this trial

What is this clinical trial studying?

A study testing Chiropractic adjustment in people with Subluxation, run by Life University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: paused, as of the sponsor's last update on 30 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Participant blinding (time frame: Immediately post-session 1 (day 1)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06931600, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Mar 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in